Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 10,037 | 8,634 | N/A |
| TOTAL | $11,799 | $8,665 | $N/A |
| Non-Current Assets | |||
| PPE Net | 16 | 9 | N/A |
| Other Non-Current Assets | 9 | 8 | 0 |
| TOTAL | $25 | $17 | $N/A |
| Total Assets | $11,824 | $8,682 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 78 | 115 | 0 |
| Accrued Expenses | 1,096 | 370 | N/A |
| Other current liabilities | 1,192 | 1,344 | N/A |
| TOTAL | $2,366 | $4,500 | $N/A |
| Non-Current Liabilities | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Liabilities | $2,366 | $4,500 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 1 | 1 | N/A |
| Retained earnings | -61,503 | -56,233 | N/A |
| Other shareholders' equity | 69,839 | 59,549 | 0 |
| TOTAL | $9,458 | $4,182 | $N/A |
| Total Liabilities And Equity | $11,824 | $8,682 | $0 |